News & events

News and events

  • Blog Post /

    Benchmarking the Frontiers on Cancer

    On lung cancer, the Standard Model posted the highest headline score of any model tested, and on breast cancer was within the 95% confidence intervals of frontier models.

  • Event / / Virtual

    Kevin Brown Joins Flare Capital’s Expert Roundtable on Agentic AI Infrastructure in Healthcare

    Standard Model Biomedicine CEO and Cofounder Kevin Brown joins agent-infrastructure founders, frontier-lab researchers, and health system and life sciences operators to discuss what it takes to move AI agents from demos to production — from post-training and agentic harnesses to the emerging role of world models in simulation and prediction.

  • Blog Post /

    Zero Shot Results: Standard Model Answered the Toughest Clinical Questions Without Ever Being Trained.

    SMB released the first version of the Standard Model™, a JEPA multimodal, multi-scale world model, releasing the first look at our capabilities to build a universal patient representation, “A Multidimensional Biological Reasoning Engine”. One of the best and most difficult ways to test a world model is by zero shot inference, “Can the model predict outcomes or draw conclusions from patients it has never seen before?” That’s the Billion Dollar Question.

  • Company Blog Post /

    Celebrating Dr. David Laub – PhD Defense: Scaling Biological Sequence Models at Standard Model Biomedicine

    David’s doctoral research addresses one of the fundamental barriers in computational genomics—the massive data storage and loading bottlenecks that hinder training deep learning models on personalized genomes. Through his PhD work and his key contributions at SMB, David is fundamentally changing how biobank-scale genomic data is ingested and modeled. David led key Computational Breakthroughs at UCSD: GenVarLoader & GenVarFormer.

  • Company /

    Standard Model Biomedicine Appoints Julie Gerardi to Lead Business Development and Strategy

    Biotech commercial veteran Julie Gerardi joins Standard Model to lead commercial strategy, go-to-market, and strategic partnerships — bringing 25+ years scaling life science companies from Bioptimus to Tempus AI and Parse Biosciences.